R J Biotech

R J Biotech Gross Margin

Delisted·Sep 16, 2026

The Gross Margin of R J Biotech (536456.BO) as of Oct 29, 2026 is 52.77 %. In the previous year, Gross Margin was 4.42 % — a change of 1,095.31% (higher).

Gross Margin

52.77 %

YoY

1,095.31%

Last updated:

Gross Margin of R J Biotech is 2022 52.77 % . Gross Margin of R J Biotech was 2021 4.42 % . It decreases by 1,095.31% higher compared to the previous year.

R J Biotech's gross margin stands at 52.8%, up from 12.5% several years earlier.

The R J Biotech Gross Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Margin
Date
Gross Margin
Jan 1, 2015
74.29 INR
Jan 1, 2016
60.60 INR
Jan 1, 2017
20.80 INR
Jan 1, 2018
12.48 INR
Jan 1, 2019
38.23 INR
Jan 1, 2020
53.58 INR
Jan 1, 2021
4.42 INR
Jan 1, 2022
52.77 INR
The R J Biotech Gross Margin history
YEARGross MarginYoY
52.77 %+1,095.31%
4.42 %-91.76%
53.58 %+40.15%
38.23 %+206.35%
12.48 %-40.02%
20.80 %-65.67%
60.60 %-18.42%
74.29 %+7.06%
69.39 %+10,310.57%
0.67 %-3.59%
0.69 %-1.68%
0.70 %+4.15%
0.68 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

R J Biotech Stock analysis

What does R J Biotech do? R J Bio-Tech Ltd. generates revenue through the research, development, and commercialization of proprietary hybrid seeds. The company focuses on field crops such as Hybrid Bajra Amol, Hybrid Bajra RJBH-555, BG-II Cotton Hybrid Tukaram, Elite Paddy Janaki-1010, and Hybrid Paddy Chetak-115 (Maruti-115), as well as vegetable and oil seed crops. Its primary customers are farmers and agricultural businesses seeking high-yield, nutritionally enhanced seeds for cultivation in Maharashtra and beyond. The firm leverages its germplasm collection of over 2700 varieties and processing plants with a combined annual capacity of 45,000 MT to support seed production and distribution. The company’s product portfolio targets key agricultural segments including fiber crops like cotton, cereal crops such as paddy, maize, and bajra, and vegetable crops. By developing hybrids with specific nutritional and economic traits, R J Bio-Tech Ltd. addresses market demands for improved crop yields and quality. Its infrastructure, including three testing locations and a storage facility exceeding 40,000 square feet, ensures efficient production and quality control for its seed offerings. R J Bio-Tech Ltd. sells seeds directly to farmers and agricultural enterprises, focusing on the Indian market with a strong presence in Maharashtra. The firm’s revenue streams are derived from the sale of its proprietary seed varieties, supported by its extensive germplasm library and processing capabilities. The company’s business model emphasizes innovation in seed technology to meet the evolving needs of the agricultural sector. R J Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about R J Biotech stock

Gross Margin of R J Biotech is 52.77 % in 2022.

Gross Margin of R J Biotech changed from 4.42 % to 52.77 %, representing a 1,095.31% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin R J Biotech since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's R J Biotech with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — R J Biotech

All Key Metrics — R J Biotech